Recent findings from a comprehensive review conducted by researchers at the University of New South Wales have raised significant concerns about the health implications of vaping, particularly its potential to cause lung and oral cancers. This study underscores the urgent need for regulatory authorities to address the burgeoning popularity of e-cigarettes before conclusive long-term data becomes available.
Early Warning Signs of Cancer
The research, which synthesised evidence from various sources, including animal studies, human case reports, and laboratory experiments, highlights early indicators of cancer risk associated with vaping. Co-author Adjunct Professor Bernard Stewart pointed out that the inhalation of e-cigarette vapour appears to induce biological changes in the cells of the mouth and lungs, including inflammation and DNA damage—known precursors to cancer. Published in the journal *Carcinogenesis*, this review suggests that the biological alterations instigated by vaping warrant serious attention from health regulators.
Stewart stated, “There is no doubt that the cells and tissues of the oral cavity, the mouth and the lungs are altered by inhalation from e-cigarettes.” This assertion is grounded in a growing body of evidence that suggests vaping is not merely a harmless alternative to smoking but may pose significant health risks in its own right.
The Challenge of Definitive Risk Assessment
Given that modern e-cigarettes have only been on the market since the early 2000s, there is a notable lack of extensive long-term data on vapers who have developed cancer. Many individuals who use e-cigarettes also continue to smoke traditional tobacco products, complicating the differentiation of the health effects attributable solely to vaping.
As a result, the review refrains from estimating the precise number of individuals likely to develop cancer as a direct consequence of vaping. Instead, the researchers focused on identifying the types of biological changes associated with cancer development. Importantly, the review included anecdotal evidence from dental practitioners who have observed cases of oral cancer in patients who exclusively vaped, as well as studies indicating that mice exposed to e-cigarette vapour exhibited a higher incidence of lung tumours.
Regulatory Implications and Public Health Concerns
Lead author Associate Professor Freddy Sitas cautioned against complacency, drawing parallels with the historical recognition of smoking as a cause of lung cancer. It took decades of accumulating evidence for the US Surgeon General to make this declaration in 1964. “We risk repeating that same fate with vaping if we don’t take emerging research and warning signs seriously,” he warned.
Calvin Cochran, a research fellow from the University of Otago, emphasised the importance of treating studies like this with the gravity they deserve. He noted that the current body of evidence, while still developing, indicates a potential cancer risk that policymakers must address proactively rather than reactively. He stated, “There is likely going to be no planting the flag moment where we can conclusively say vaping causes x, y, z types of cancer. That is years and most probably decades away.”
A Call for Urgent Action
Experts agree that while vaping has often been viewed as a safer alternative to smoking, the new findings challenge this assumption. “We’ve always assumed that vapes are safer than cigarettes, but you know, what we’re showing is that they might not be safe after all,” Sitas remarked. He stressed the need for effective cessation programmes specific to vaping, as current methods for quitting smoking do not necessarily translate to successful strategies for reducing e-cigarette use.
Professor Stephen Duffy from Queen Mary University London cautioned against overstating the risks, noting that while vaping does not expose users to the combustion products of tobacco, it is crucial to assess its potential for causing cancer independently. Conversely, Professor Becky Freeman from the University of Sydney stated, “This study is the first to assert that there is likely an increased cancer risk for people who vape, compared to people who do not vape.”
Why it Matters
The implications of this research extend far beyond academic discourse; they signal a pressing public health challenge. As vaping continues to gain traction, especially among younger populations, the potential health risks associated with e-cigarette use must be taken seriously. Governments and health organisations are urged to consider these findings in their regulatory frameworks, ensuring that preventative measures are in place to protect public health. Without decisive action, we may face a future where the consequences of vaping become as dire as those we currently associate with smoking.
